SC

Subhash Chand

Active Director Director DIN 10397725
DIN 10397725 First appointment Nov 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value •••• Premium profile

About Subhash Chand

Data last updated:

Subhash Chand is a Director at Noxin Biocare Private Limited (since 2023). The company operates in Paper. Noxin Biocare Private Limited reported revenue of ₹20.8 Lakh (FY 2024).

DIN 10397725
Primary Designation Director
Industry Paper
First Appointment 20 Nov 2023
Oldest Company Age 2 yrs
Largest company Noxin Biocare Private Limited · ₹20.8 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Noxin Biocare Private Limited U21002HR2023PTC116615
Director20 Nov 20232023₹20.8 Lakh (FY 2024)Active

Board colleagues of Subhash Chand

NameDINCompanyDesignation
Baby10397726Noxin Biocare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Noxin Biocare Private Limited
Premium access

Shareholding and investment profile for Subhash Chand

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subhash Chand

Subhash Chand currently holds 1 directorship: Noxin Biocare Private Limited (Director, since 20 Nov 2023, revenue ₹20.8 Lakh (FY 2024)).

Subhash Chand was first appointed on 20 Nov 2023 as Director at Noxin Biocare Private Limited.

The current boards of Subhash Chand's companies include Baby (Noxin Biocare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available